Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP282041.RAF1XLT12-Fae9nTcA6hZs6XrSvZFEadlXATDNZIk0NP4130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP282041.RAF1XLT12-Fae9nTcA6hZs6XrSvZFEadlXATDNZIk0NP4130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP282041.RAF1XLT12-Fae9nTcA6hZs6XrSvZFEadlXATDNZIk0NP4130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP282041.RAF1XLT12-Fae9nTcA6hZs6XrSvZFEadlXATDNZIk0NP4130_provenance.
- NP282041.RAF1XLT12-Fae9nTcA6hZs6XrSvZFEadlXATDNZIk0NP4130_assertion description "[LY294002 and rapamycin also inhibit growth factor- and mitogen-induced secretion of vascular endothelial growth factor, the product of a known HIF-1 target gene, thus linking the PI3K/PTEN/AKT/FRAP pathway, HIF-1, and tumor angiogenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP282041.RAF1XLT12-Fae9nTcA6hZs6XrSvZFEadlXATDNZIk0NP4130_provenance.
- NP282041.RAF1XLT12-Fae9nTcA6hZs6XrSvZFEadlXATDNZIk0NP4130_assertion evidence source_evidence_literature NP282041.RAF1XLT12-Fae9nTcA6hZs6XrSvZFEadlXATDNZIk0NP4130_provenance.
- NP282041.RAF1XLT12-Fae9nTcA6hZs6XrSvZFEadlXATDNZIk0NP4130_assertion SIO_000772 10749120 NP282041.RAF1XLT12-Fae9nTcA6hZs6XrSvZFEadlXATDNZIk0NP4130_provenance.
- NP282041.RAF1XLT12-Fae9nTcA6hZs6XrSvZFEadlXATDNZIk0NP4130_assertion wasDerivedFrom befree-20140225 NP282041.RAF1XLT12-Fae9nTcA6hZs6XrSvZFEadlXATDNZIk0NP4130_provenance.
- NP282041.RAF1XLT12-Fae9nTcA6hZs6XrSvZFEadlXATDNZIk0NP4130_assertion wasGeneratedBy ECO_0000203 NP282041.RAF1XLT12-Fae9nTcA6hZs6XrSvZFEadlXATDNZIk0NP4130_provenance.
- befree-20140225 importedOn "2014-02-25" NP282041.RAF1XLT12-Fae9nTcA6hZs6XrSvZFEadlXATDNZIk0NP4130_provenance.